AIMOVIG vs JANUMET XR

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. AIMOVIG and JANUMET XR are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	AIMOVIG	JANUMET XR
Rating	72/100	New
Pharmacy pays	—	~$0.74 /30
Type	RX	RX
Active ingredient	ERENUMAB-AOOE	METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE
Manufacturer	Amgen Inc	Msd Sub Merck
Dosage forms	Injectable, Solution	Tablet, extended release
Drug class	—	—
Boxed warning	None	Boxed warning
Half-life	—	about 12.4 hours (apparent terminal half-life after a single 100 mg oral dose in healthy volunteers)

aimovig janumet xr

Rating

72/100

New

Pharmacy pays

—

~$0.74 /30

Type

Active ingredient

ERENUMAB-AOOE

METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE

Manufacturer

Amgen Inc

Msd Sub Merck

Dosage forms

Injectable, Solution

Tablet, extended release

Drug class

—

Boxed warning

None

Boxed warning

Half-life

—

about 12.4 hours (apparent terminal half-life after a single 100 mg oral dose in healthy volunteers)

Frequently asked questions

What is the difference between Aimovig and Janumet XR?

Aimovig contains Erenumab-Aooe, while Janumet XR contains Metformin Hydrochloride and Sitagliptin Phosphate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.